The role of the 'lifestyle' label and negative bias in the allocation of health resources for erectile dysfunction drugs: An ethics-based appraisal

International Journal of Impotence Research

Volumn 18, Issue 1, 2006, Pages 98-103

  Manson, H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Ageing; Allocation of resources; Drugs; Erectile dysfunction; Ethics

Indexed keywords

SILDENAFIL;

AGING; ARTICLE; CARDIOVASCULAR RISK; CULTURAL FACTOR; DEPRESSION; EJACULATION; ERECTILE DYSFUNCTION; HEALTH CARE; HEALTH CARE UTILIZATION; HUMAN; HYPERLIPIDEMIA; LIFESTYLE; MARRIAGE; MEDICAL ETHICS; PENIS ERECTION; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL BEHAVIOR; SEXUAL HEALTH; SEXUALITY; SOCIAL PSYCHOLOGY; WELLBEING;

AGE FACTORS; BIAS (EPIDEMIOLOGY); HEALTH RESOURCES; HUMANS; IMPOTENCE; LIFE STYLE; MALE; PATIENT SELECTION; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 30044431862     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901409     Document Type: Article

References (31)

1. Independent Advisory Group on Sexual Health and HIV. Response to the Health Select Committee Report on Sexual Health. Department of Health: London, January 2004, p. 7.
2. Curry T. House Members Protest Medicare Viagra©. MSNBC News, 10th February 2005 http://msnbc.msn.com/id/6941445.
3. Pear R. Companies Fight to Ensure Coverage for Erectile Drugs. New York Times, February 22nd 2005.
4. Lewis R, Hatzichristou D, Laumann E, McKinlay J. Epidemiology and natural history of erectile dysfunction. In: Jardin A et al. (ed). Erectile Dysfunction: First International Consultation on ED. Plymbridge Distributors Ltd: Plymouth, 2000, pp. 32-35.
5. National Institutes of Health Consensus Development Panel on Impotence. Impotence. JAMA 1993; 270: 83-90.
6. Seidman SN. Exploring the relationship between depression and erectile dysfunction in aging men. J Clin Psychiatry 2002; 63(Suppl 5): 5-12.
7. Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998; 52: 848-852.
8. Riley A. Erectile dysfunction is a symptom, not a diagnosis. Men's Health Journal 2001; 1: 8-12.
9. Althof SE. Quality of life and erectile dysfunction. Urology 2002; 59: 803-810.
10. Guest JF, Das Gupta R. Health-related quality of life in a UK-based population of men with erectile dysfunction. Pharmacoeconomics 2002; 20: 109-117.
11. McCabe MP. Intimacy and quality of life among sexually dysfunctional men and women. J Sex Marital Ther 1997; 23: 276-290.
12. Schiavi RC, Rehman J. Sexuality and aging. Urol Clin N Am 1995; 22: 711-726.
13. Gheorghiu S, Godschalk M, Gentili A, Mulligan T. Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction. J Urol 1996; 156: 80-81.
14. Paige NM, Hays RD, Litwin MS, Rajfer J, Shapiro MF. Improvement in emotional well-being and relationships of users of Sildenafil. J Urol 2001; 166: 1774-1778.
15. Fugl-Meyer AR, Lodnert G, Branholm I-B, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141-148.
16. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol 2000; 86(Suppl 1): 41-45.
17. Jackson G, Giuliano F. Moderators' introduction. Fundamentals in diagnosing and treating erectile dysfunction. Eur Heart J Suppl 2002; 4(Suppl H): H1-H6.
18. Wilson ECF, McKeen ES, Scuffham PA, Brown MCJ, Wylie K, Hackett G. The cost to the United Kingdom National Health Service of managing erectile dysfunction. Pharmacoeconomics 2002; 20: 879-889.
19. De Berardis G, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH. Erectile dysfunction and quality of life in Type 2 diabetic patients. Diabetes Care 2002; 25: 284-291.
20. Morales A, Choi H, Giami A, Gingell C, Johnston B, Pasini W. Socio-cultural, educational and ethical aspects of erectile dysfunction. In: Jardin A et al. (ed). Erectile Dysfunction: First International Consultation on ED. Plymbridge Distributors Ltd: Plymouth, 2000, 585 pp.
21. Mechanic D. Dilemmas in rationing health care services: the case for implicit rationing. BMJ 1995; 310: 1655-1659.
22. Klein K, Sturm H. Viagra©: a success story for rationing? Health Affair 2002; 21: 177-187.
23. Stolk EA, Brouwer WBF, Busschbach JJV. Rationalising rationing: economic and other considerations in the debate about funding of Viagra©. Health Policy 2002; 59: 53-63.
24. Titlow K, Randel L, Clancy CM, Emanuel EJ. Drug coverage decisions: the role of dollars and values. Health Affair 2000; 19: 240-248.
25. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachussetts male aging study. J Urol 1994; 151: 54-59.
26. Morley J. Impotence. Am J Med 1986; 80: 897-905.
27. Daniels N. Just Health Care. Cambridge University Press: New York, 1985; 26-35.
28. Braun M, Wassmer G, Klotz T, Reifenrath B, Mahers M, Engelmann U. Epidemiology of erectile dysfunction: results of the Cologne Male survey. Int J Impot Res 2000; 12: 305-311.
29. Gott M, Hinchcliff S. How important is sex in later life? The views of older people. Social Sci Med 2003; 56: 1617-1628.
30. Grimley Evans J. The rationing debate: rationing health care by age: the case against. BMJ 1997; 314: 822.
31. Daniels N, Sabin JE. Setting Limits Fairly: Can We Learn to Share Medical Resources? Oxford University Press: New York, 2002, pp. 43-66.